Bob Lenich joins podcast host Jim Cahill to discuss how the Process Knowledge Management (PKM) digital collaboration platform can help streamline the process and minimize errors, resulting in faster time-to-market for pharmaceutical & biopharmaceutical manufacturers.
Posts by or with Bob Lenich
Traceability Across the Entire Drug Development Pipeline
Recently, as cell and gene therapies have begun to emerge in the life sciences manufacturing landscape, an important concept has begun to draw attention: traceability. However, it is important to remember that traceability was critical long before today’s most...
Remote Monitoring Lays the Foundation for Lights-Out Manufacturing
It isn’t news that the global pandemic upended the way we operate our plants. When social distancing trapped our most valuable personnel outside the facilities we rely on, it suddenly meant finding new ways to get critical work done. But the reality is, those changes...
Improve Speed to Market with Closed-Loop Process Control using Spectral PAT
We have witnessed an incredible change the last few years in how life sciences manufacturers deliver treatments. Today’s focus is on fast results, and that means products patients rely on cannot sit on shelves for weeks or months waiting on quality validation. In a...
A More Measured Move to the Pharma Cloud
There is little doubt that the recent explosion in available cloud technologies has been a boon for manufacturing across a wide array of industries. Pharmaceutical manufacturers are no exception, and organizations are now carefully considering where leveraging cloud...
Modular Plug and Play, MTP Will Enable More Flexible Life Sciences Manufacturing
Modular facilities are a key enabler of speed to market in life sciences. As organizations try to bring new therapies to market faster, those therapies require a wide variety of equipment—many of which are new to the process. These new machines must not only work...
Oral Solid Drug Continuous Manufacturing
In a May 19 BioPharma Asia webinar, Continuous Manufacturing as a Default Platform for Oral Solid Drug Products, Emerson’s Bob Lenich will team up with Johnson and Johnson Senior Principal Engineer Lawrence De Belder to discuss the path to continuous manufacturing for these types of medicines.
Biopharmaceutical Models in Development and Production
Models of manufacturing and production processes can provide value through the lifecycle of these facilities, from up front design through ongoing personnel training and optimization. In a BioPharm International article, Biopharma modeling, now and five years from no…
Technology Trends for Life Sciences Manufacturers
We seem to be fully in the swing of industry conferences. This week is the pharmaceutical and biotech manufacturing industries' INTERPHEX conference in New York City. It: …brings over 11,000 global industry professionals and 650+ leading suppliers together to "Learn...
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.








